Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy

In this study, we investigated the relationships of pathological response after neoadjuvant chemo-endocrine therapy with alterations in the Ki67 labeling index (LI), expression of cyclin D1 (CCND1) and progesterone receptor (PgR), and estrogen receptor (ER) activity in breast cancer. A total of 43 J...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Kurozumi, Sasagu, Yamaguchi, Yuri, Matsumoto, Hiroshi, Kurosumi, Masafumi, Hayashi, Shin-ichi, Fujii, Takaaki, Horiguchi, Jun, Shirabe, Ken, Inoue, Kenichi
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528995/
https://ncbi.nlm.nih.gov/pubmed/31112577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0217279
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares